1. Home
  2. PHIO vs DTSS Comparison

PHIO vs DTSS Comparison

Compare PHIO & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$0.65

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.36

Market Cap

8.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHIO
DTSS
Founded
2003
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.2M
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
PHIO
DTSS
Price
$0.65
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 53.7K
48.4K
Earning Date
11-05-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.70
$0.40
52 Week High
$1.88
$2.29

Technical Indicators

Market Signals
Indicator
PHIO
DTSS
Relative Strength Index (RSI) 27.10 25.90
Support Level N/A N/A
Resistance Level $1.12 $0.77
Average True Range (ATR) 0.07 0.05
MACD -0.01 -0.02
Stochastic Oscillator 5.14 0.30

Price Performance

Historical Comparison
PHIO
DTSS

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC) markets.

Share on Social Networks: